Early stage patients with triple-positive breast cancer have to determine their survival period according to the size of the tumor and whether there is any lymph node metastasis, etc. The five-year survival rate of some patients after treatment is about 95%. Breast cancer is a common malignant tumor in women, which can be caused by heredity, hormone level and other factors. In the early stage of the disease, radical surgical resection is often feasible due to the limitation of the lesion, after which radiotherapy is supplemented according to the condition, and a better prognosis can often be achieved. After active treatment, some early-stage patients can obtain a five-year survival rate of about 95%. However, the specific survival period needs to be determined according to the size of the tumor and whether there is any lymph node metastasis. Triple-positive, i.e., estrogen, progesterone, and HER2 receptor positive, has a better prognosis than triple-negative breast cancer. Although the prognosis is better, patients should still pay attention to regular review as prescribed by the doctor, maintain good habits in daily life, and exercise appropriately in order to prolong the survival period.